Which of the following is NOT a cause of congenital hypercoagulability aEUR’
The options given are A, B, C, D. The correct answer is one of them that isn't a congenital cause. Let's think about possible distractors. Sometimes, acquired hypercoagulable states are confused with congenital ones. For example, antiphospholipid syndrome is an acquired condition. Also, things like cancer or pregnancy are acquired risk factors. So if any of the options list an acquired condition, that would be the correct answer here.
Another angle: maybe one of the options is a normal variant or a different type of disorder. For example, if an option mentions a condition like deep vein thrombosis (DVT) itself, that's a clinical manifestation, not a cause. Or perhaps a condition that's not related to clotting factors, like a bleeding disorder. For instance, hemophilia is a bleeding disorder and wouldn't be a cause of hypercoagulability. So if one of the options is hemophilia, that's the answer.
Wait, but the question is about hypercoagulability. So the incorrect answer would be something that's not a known congenital cause. Let me list possible congenital causes again: Factor V Leiden, Prothrombin mutation, Antithrombin deficiency, Protein C deficiency, Protein S deficiency. If any option includes something like Antiphospholipid antibodies (which is acquired), or maybe a different condition like Von Willebrand disease (which is a bleeding disorder), that would be the answer.
So, if the options are something like:
A. Factor V Leiden
B. Antithrombin III deficiency
C. Protein C deficiency
D. Antiphospholipid syndrome
Then D is the correct answer because it's an acquired condition. The question is asking for which is NOT a cause. So the correct answer would be the one that's acquired. Therefore, the student needs to distinguish between congenital and acquired hypercoagulable states. The key here is knowing that antiphospholipid syndrome is an autoimmune disorder, not genetic, so it's acquired. Other options are all genetic.
**Core Concept**
Congenital hypercoagulability arises from inherited genetic mutations affecting clotting factors or anticoagulant proteins. Key examples include Factor V Leiden, Prothrombin G20210A mutation, and deficiencies in Antithrombin III, Protein C, or Protein S. These conditions predispose individuals to thromboembolic events due to impaired regulation of coagulation pathways.
**Why the Correct Answer is Right**
Antiphospholipid syndrome (if listed) is an **acquired** autoimmune disorder characterized by antibodies against phospholipids and clotting proteins, leading to hypercoagulability. It is not inherited and thus does not fall under congenital causes. This distinction is critical for accurate diagnosis and